Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene citrate added to dydrogesterone-based progestin-primed ovarian stimulation in normal ovulatory women
ChiCTR1800015619Phase 3Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in infertility comparing HMG + dydrogesterone with HMG + dydrogesterone + clomiphene citrate (2 arms). Primary endpoint: Number of oocytes retrieved. Started Apr 2018; status: recruiting.
02
Drugs
clomiphenedydrogesteronehuman menopausal gonadotrophin
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR1800015619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015619.